REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 2 filers reported holding REVOLUTION MEDICINES INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,610,477 | +2.6% | 274,945 | -0.9% | 0.00% | 0.0% |
| Q2 2023 | $7,420,182 | +143368.3% | 277,390 | +16.1% | 0.00% | +50.0% |
| Q1 2023 | $5,172 | +8.0% | 238,821 | +18.7% | 0.00% | 0.0% |
| Q4 2022 | $4,791 | -99.9% | 201,152 | -13.3% | 0.00% | 0.0% |
| Q3 2022 | $4,577,000 | +11.0% | 232,104 | +9.7% | 0.00% | 0.0% |
| Q2 2022 | $4,122,000 | -5.0% | 211,492 | +1.2% | 0.00% | +100.0% |
| Q1 2022 | $4,338,000 | -20.3% | 208,968 | -3.3% | 0.00% | -50.0% |
| Q4 2021 | $5,440,000 | -42.2% | 216,117 | -36.9% | 0.00% | -33.3% |
| Q3 2021 | $9,416,000 | -19.8% | 342,275 | -7.5% | 0.00% | -25.0% |
| Q2 2021 | $11,743,000 | +23.4% | 369,980 | +78.4% | 0.00% | +33.3% |
| Q1 2021 | $9,515,000 | +57.2% | 207,378 | +35.7% | 0.00% | +50.0% |
| Q4 2020 | $6,052,000 | +14.3% | 152,860 | +0.5% | 0.00% | 0.0% |
| Q3 2020 | $5,294,000 | +30.0% | 152,147 | +18.0% | 0.00% | 0.0% |
| Q2 2020 | $4,071,000 | +130.5% | 128,937 | +60.0% | 0.00% | +100.0% |
| Q1 2020 | $1,766,000 | – | 80,585 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,524,031 | $175,333,000 | 30.61% |
| TRV GP IV, LLC | 1,419,900 | $45,068,000 | 21.46% |
| Ponoi II Management, LLC | 685,011 | $21,742,000 | 17.62% |
| Column Group LLC | 3,347,245 | $106,242,000 | 15.04% |
| Ponoi Management, LLC | 685,011 | $21,742,000 | 12.08% |
| Boxer Capital, LLC | 3,484,264 | $110,591,000 | 3.90% |
| Cormorant Asset Management, LP | 3,338,166 | $105,953,000 | 3.60% |
| BVF INC/IL | 2,485,049 | $78,875,000 | 2.96% |
| Casdin Capital, LLC | 2,305,000 | $73,161,000 | 1.86% |
| Burrage Capital Management LLC | 50,000 | $1,587,000 | 1.59% |